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The aim of this retrospective study is to evaluate the long-term followup of soft penile SSDA prosthesis, without plaque surgery
in the treatment of Peyronie’s disease. This study included 12 men with Peyronie’s disease who underwent placement of a penile
prosthesis.Allpatientswerefollowedforatleast6years.Prosthesisstraightenedthepenileshaftinallcases,restoringpatientsexual
satisfaction. No operative or postoperative complications occurred, and no reoperations were needed. All patients have undergone
further examination with basal and dynamic eco color Doppler. The ﬁndings are encouraging as the penis preserves the ability to
enhance the tumescence and penile girth. We can conclude that SSDA penile prosthesis is safe and eﬀective in Peyronie’s disease.
Copyright © 2008 Marco Grasso et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
In 1743, de la Peyronie ﬁrst described the characteristic
penile curvature, nowadays known as Peyronie’s disease or
induratio penis plastica (IPP) [1]. In general, IPP refers
to acquired penile deformities during erection (curvature
and strictures) and/or penile shortening. This condition
is usually associated with palpable hardening (plaque) on
the penile shaft and eventually painful erection. Current
researches suggest that IPP could be a localized connective
tissue disorder aﬀecting the tunica albuginea of the corpora
cavernosa.
The aetiology of the disease remains unknown and
many hypotheses have been formulated so far. Trauma is
thought tobe the promoterfactorofIPP,causingmechanical
stress and microvascular damage. As a consequence, even
genetically induced, hyperactive wound healing may cause
chronic inﬂammation and ﬁbrosis of tunica albuginea with
subsequent development of hardening and deformation of
the penile shaft characteristic of the stabilized phase of
disease.
Another hypothesis is related to a defect of immune
response causing antibody reaction against the tunica albug-
inea. IPP can occur in a familiar pattern and it has been
reported in association with Dupuytren’s disease as well.
Over years, various medical treatments such as radiation,
laser therapy, ultrasound, shock wave lithotripsy have been
reported without any of them being superior to others.
However, surgery is considered the only eﬀective treatment
for stabilized disease when severe curvature or narrowing
interferes with sexual intercourse [2–4].
Several surgical options have been proposed. Tunica
shortening procedures are performed by reducing the length
of the convex side of the penis opposite to the penile plaque
(Nesbitt or Yachia procedures; plication of corpora caver-
nosa). Conversely, lengthening techniques are performed
by plaque incision or excision while the resulting defect is
then covered by a graft. As a result, the extension of the
short side of the penile curvature gives the penile shaft
the original length [2, 4–6]. Another possible treatment,
especially with associated erectile dysfunction, is penile
prosthesis placement. These surgical treatments warrant
adequate correction of penile curvature and recovery of
patient sexual satisfaction [7–9].
We have treated a patient series by placing a particular
semirigid soft penile prosthesis (silicon soft dynamic antiex-
trusion (SSDA)) in which the cavernous tissue is displaced2 Advances in Urology
Table 1
Age No. of patients
30–40 1
40–50 3
50–60 7
60–70 1
Total 12
by prosthesis shaft as a peripheral layer of cavernous
surrounding tissue.
Our hypothesis was that the residual function of this
cavernous tissue could have a positive impact on penile
curvature treatment and patient satisfaction. We report our
retrospective study with a long-term followup.
2. MATERIAL AND METHODS
Between1998and2001,12patients(36to67years)(Table 1)
were treated by soft penile prosthesis placement (SSDA). All
patientspresentederectiledysfunctionassociatedwithpenile
deformation. We previously excluded patients with diabetes
and vasculogenic impotence. A severe penile shortening was
reported in 6 patients. All patients were previously treated
by various medical and physical therapies without any
beneﬁt. In all patients, the plaque was easily palpable on the
penile shaft. Erectile function was tested by duplex dynamic
color Doppler ultrasound, nocturnal penile tumescence, and
hormone assay.
2.1. DescriptionofSSDAprosthesisand
surgicalprocedure
We reviewed our experience with implants on soft penile
prosthesis called silicon soft dynamic antiextrusion (SSDA)
(Figure 1). This prosthesis consists of silicone elastomer
which has three zones with diﬀerent features:
(i) the central zone has a variable rigidity and size to
satisfy diﬀerent clinical necessities and to permit an
easy insertion;
(ii) the distal zone is made of softer silicone to reduce the
risk of extrusion;
(iii) the proximal zone presents a series of slightly cone-
shaped segments, with a size of 3mm, smaller than
the central zone, to facilitate the insertion into
corpora cavernosa. It requires less dilatation even in
the presence of severe ﬁbrosis and can reduce crural
pain because of better ﬂexibility [7, 8].
2.2. Surgicalprocedure
A penoscrotal longitudinal incision is our preferred surgical
approach for SSDA prosthesis placement. Trichotomy is
performed two hours before surgery and short-term antibi-
otic prophilaxis (Piperacillin 2g and Netilmicin 150mg) is
Table 2
No. of sexual intercourses in a month No. of patients
Less than 1 1
Between 1 and 6 7
More than 6 4
administered. The patient is placed in lithotomic position
under spinal anaesthesia. We perform a minimal longitudi-
nally corporotomy (<2cm), on each corpora cavernosa, and
then we place the cylinder with appropriate length through
the corporotomy. Routinely, a transurethral catheter is left
in place until the ﬁrst postoperative day. Each patient has
been followed up until the surgical wound had healed and
any surgical complications have been recorded in detail.
Patients were then taught to manipulate the penile prosthesis
and were allowed to start sexual activity after 6 weeks
[10].
2.3. Followup
All patients underwent an annual clinical assessment. All
patients reached a 6 years minimum followup. At this time,
a questionnaire was administered to the patient and his
partner. The questions regarded the frequency of sexual
intercourse per month, the acceptance degree by patient and
his partner (range 0–10), and the overall sexual satisfaction.
In order to investigate the postoperative residual function of
the corpora cavernosa, all patients were evaluated by color
Doppler dynamic ultrasonography (Esaote-Technos, probe
7, 5–10 MHz) before and after taking oral 50mg Sildenaﬁl
associated to visual sex stimulation. We measured thickness
of cavernous tissue, peak systolic velocity, and the presence
of plaques.
3. RESULTS
The implantation of an SSDA prosthesis straightened the
penile shaft in all cases indicating a good surgical outcome
and restored sexual satisfaction. All the patients have been
discharged within the third postoperative day. We did not
have any intraoperative complications. Only one patient had
a wound infection without permanent consequences. No
subsequent postoperative complications were encountered.
Only one man reported less than 1 sexual intercourse in a
month,7menindicatedhaving1to6sexualintercoursesand
4 men more than 6 sexual intercourses (Table 2). The degree
of acceptance by couple was 7, 2 (range 4–10) for men and 7,
8 (range 5–9) for the partner. The overall sexual satisfaction
was positive in 11 patients (Table 3). The color Doppler
dynamic ultrasonography showed a signiﬁcant thickness
increase of cavernosal tissue (5 to 9mm) as well as peak
systolic velocity increase (7.5 cm/s to 16.5 cm/s) after the
dynamic phase; no plaques were detected (Table 4) (Figures
2 and 3; Figures 4 and 5). In all cases, we noted an almost
complete straightening of the penile shaft.Marco Grasso et al. 3
Table 3
Mean Range
Acceptance degree for men (1–10) 7, 2 4–10
Acceptance degree for partner (1–10) 7, 8 5–9
Overall satisfaction (yes-no) Yes 11pts (91%) No 1pt (9%)
Table 4
Basal Dynamic
Range Mean Range Mean
Thickness of cavernosal tissue 1,7–2,2mm 1,9mm 2,8–7,2mm 5mm
Peak systolic value 6–9cm/sec 7,5cm/sec 13–20cm/sec 16,5cm/sec
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Figure 1: Prosthesis SSDA.
Figure 2: Basal cavernosal ﬂow.
4. DISCUSSION
The natural history of IPP can be summarized into early
and late stages. The early stage is characterized by reactive
inﬂammation with multifocal spreading into the tunica
albuginea. Clinically, a palpable nodule or plaque that makes
penis deformed in its shape during a usually painful erection
can be shown. In the second phase, ﬁbrosis and calciﬁcation
of acute inﬂammation take place making the plaque hard
and steadily causing a stable penile curvature, stricture, and
some grade shortening during erection. Reduction of both
cavernous blood supply and the possibility of venous leakage
due to the rigidity of tunica albuginea may cause some grade
of erectile dysfunction.
This histological evolution seems to be constant, while
the progression and timing of disease remain unpredictable.
We do not have well-deﬁned criteria to establish the end of
the process: a quote of patients indeed presents recurrence
after long time. Moreover, in younger patients, the course
m a yb em o r es e v e r e[ 11].
For these reasons, in our opinion the surgical treatment
of Peyronie’s disease should be as simple as possible, even4 Advances in Urology
Figure 3: Dynamic cavernosal ﬂow.
Figure 4: Basal thickness of cavernosal tissue.
Figure 5: Dynamic thickness of cavernosal tissue.Marco Grasso et al. 5
considering the possible multifocal spreading of ﬁbrosis.
Moreover, in order to adhere to patient’s perspectives,
the ideal prosthetic implant should provide a ﬁrm and
straightened penis, if possible, restoring the original length
or girth of the natural erection [12].
The SSDA soft prosthesis satisﬁes all these criteria as it
provides a good hardening and girth of the penis, implant is
easy to perform, it has low cost and low mechanical failure
rate while an adequate ﬂexibility warranted by structure,
shape, and by intrinsic silicone characteristics lead to a good
patient tolerance and comfort. Moreover, after implantation,
the residual cavernous surrounding tissue is kept intact
with an adequate cavernous arterial blood ﬂow making
possible its adequate expansion under sexual stimulation.
Furthermore, the characteristic softy tip lowers the pressure
of the prosthetic shaft on the tip of corpora cavernosa with
possible positive impact on pain and eventually on extrusion
rate.
Our technique does not include the plaque treatment
associated to prosthesis placement. Even in severe penile
curvature, the simple placement of the cylinders makes the
penile shaft less pronounced. Interestingly, we noted that
over time the same penile curvature decreases until almost
disappearing. It can be hypothesized that it may be due
to continuous mechanical straighten induced by prosthesis
associated with residual cavernous tissue function.
A peculiarity of our study is the dynamic study of
residual cavernous tissue that gives the basis for a role of
pharmacologic rehabilitative postoperative therapy in order
t oi n c r e a s ev a s o a c t i v er e s p o n s et os e x u a ls t i m u l a t i o na n d
improve patients’ satisfaction.
If evaluation of patient satisfaction might be considered
adequate considering the long-term followup, an even
longer followup would be needed to rule out any long-
term mechanical failure as well as spontaneous prosthesis
extrusion that did not happen in the present study.
5. CONCLUSION
Silicon soft dynamic antiextrusion penile prosthesis is safe
and eﬀective in the treatment of severe Peyronie’s disease
associated to penile deformity during erection. Results in
terms of penile curvature correction are good. The majority
ofpatientsreportasexualsatisfaction.Moreover,thepositive
response to vasoactive drugs by residual cavernous tissue
might give the rationale for a pharmacological adjuvant
rehabilitation therapy in order to improve the patient
satisfaction even in patients having an insuﬃcient residual
cavernous tissue erection.
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